S-EPMC9883251 - DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease. - OmicsDI

Unknown

Dataset Information

DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease.

ABSTRACT:

SUBMITTER: Kost SEF

PROVIDER: S-EPMC9883251 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature